Search - tctmd.com

Displaying 241 - 260 of 612

Sort: Relevancy | Date

News Daily News

‘Reassuring’ 18-Month Results Seen With Absorb BVS, but Longer-Term Follow-up Still Needed

Michael O'Riordan

August 01, 2016

News Industry News

REALITY Trial Enrolls First Patient in Study Evaluating Medtronic Directional Atherectomy and Drug-Coated Balloon in PAD Treatment

July 28, 2016

News Industry News

Medtronic Receives FDA Approval for IN.PACT Admiral DCB 150 mm Lengths

July 13, 2016

News Industry News

QT Vascular Receives CE Mark Clearance For Chocolate Heart™, A Novel Drug-Coated Coronary Balloon

July 07, 2016

News Daily News

Drug-Coated Balloons Beat Angioplasty for SFA In-Stent Restenosis, but Long-Term Solutions Needed

Caitlin E. Cox

July 07, 2016

News Daily News

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Michael O'Riordan

July 05, 2016

News Daily News

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

Michael O'Riordan

June 06, 2016

News Conference News EuroPCR 2016

Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events

Shelley Wood

May 18, 2016

News Conference News EuroPCR 2016

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Michael O'Riordan

May 17, 2016

News Daily News

Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis

Michael O'Riordan

April 25, 2016

News Daily News

Absorb BVS: Safety, Efficacy, and Stent Thrombosis Tackled in Two New Analyses

Michael O'Riordan

March 30, 2016

News Industry News

Micell Technologies Completes Enrollment in OCT Study Designed to Evaluate Superior Performance of MiStent SES Compared to Xience

March 22, 2016

News Features

Hopes and Hype Await New Coronary Revascularization Appropriate Use Criteria in 2016

Caitlin E. Cox

March 21, 2016

News Daily News

FDA Panel Overwhelmingly Supports Absorb Bioresorbable Stent

Michael O'Riordan

March 16, 2016

News Industry News

Avinger Announces FDA Clearance and U.S. Launch of Breakthrough Treatment for Patients With Peripheral Artery Disease

March 01, 2016

News Industry News

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

February 24, 2016

News Daily News

SORT OUT IV at 5 Years: Better Long-term Safety Confirmed for Second Generation Stents

L.A. McKeown

February 16, 2016

News Conference News ISET 2016

Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired

Michael O'Riordan

February 10, 2016

News Industry News

New Real-World Comparison Showing Similar Efficacy Between the Lutonix® and In.Pact™ Drug-Coated Balloons Featured at LINC 2016

February 08, 2016

News Daily News

Diabetes More Influential Than CAD Complexity in DES-Treated Patients

L.A. McKeown

February 03, 2016

Advertisement

‘Reassuring’ 18-Month Results Seen With Absorb BVS, but Longer-Term Follow-up Still Needed

REALITY Trial Enrolls First Patient in Study Evaluating Medtronic Directional Atherectomy and Drug-Coated Balloon in PAD Treatment

Medtronic Receives FDA Approval for IN.PACT Admiral DCB 150 mm Lengths

QT Vascular Receives CE Mark Clearance For Chocolate Heart™, A Novel Drug-Coated Coronary Balloon

Drug-Coated Balloons Beat Angioplasty for SFA In-Stent Restenosis, but Long-Term Solutions Needed

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis

Absorb BVS: Safety, Efficacy, and Stent Thrombosis Tackled in Two New Analyses

Micell Technologies Completes Enrollment in OCT Study Designed to Evaluate Superior Performance of MiStent SES Compared to Xience

Hopes and Hype Await New Coronary Revascularization Appropriate Use Criteria in 2016

FDA Panel Overwhelmingly Supports Absorb Bioresorbable Stent

Avinger Announces FDA Clearance and U.S. Launch of Breakthrough Treatment for Patients With Peripheral Artery Disease

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

SORT OUT IV at 5 Years: Better Long-term Safety Confirmed for Second Generation Stents

Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired

New Real-World Comparison Showing Similar Efficacy Between the Lutonix® and In.Pact™ Drug-Coated Balloons Featured at LINC 2016

Diabetes More Influential Than CAD Complexity in DES-Treated Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content